Home Medicine Chronic pain is strongly associated with work disability
Article Publicly Available

Chronic pain is strongly associated with work disability

  • Christopher Sivert Nielsen EMAIL logo
Published/Copyright: October 1, 2013
Become an author with De Gruyter Brill

In this issue of the Scandinavian Journal of Pain, Landmark et al. analyse associations between chronic pain and both objective and subjective measures of functioning [1]. Most profoundly the study reports that nearly half the work disability cases can be attributed to chronic pain.

1 Defining chronic pain

As the authors point out, there is currently no consensus definition of chronic pain in epidemiology. Though there appears to be some convergence on three or six months as a cutoff between acute and chronic pain, shorter durations have also been applied [2]. The use of additional criteria such as pain intensity or pain impact varies, as do the scales used to measure these dimensions. In many studies pain is confounded with discomfort, as is the case with the Rome III criteria for irritable bowel syndrome [3]. Taken together one is hard put to find two epidemiological studies that use the exact same definition of chronic pain, making comparisons between studies problematic to say the least.

Inconsistent definitions are most likely the major cause of the huge variation in prevalence estimates, ranging from 11 to 64 percent among adults [4,5]. Lack of comparability means that there is currently little or no grounds for concluding whether there are real differences between countries or whether chronic pain is a growing, constant or declining problem. This issue is not purely academic, but has important practical implications. With rising public healthcare costs, governments are increasingly basing priority decisions on epidemiological data sources such as the Global Burden of Disease Study [6]. Widely varying prevalence estimates and lack of a consensus definition are hardly helpful in placing chronic pain on this agenda. The 2010 wave of Global Burden of Disease Study did include some painful conditions: Notably, low-back pain was ranked 1st and neck pain was ranked 4th among causes of years lived with disability (YLD). However, chronic pain as a general category was notably absent from the study.

2 Prevalence versus impact

The societal impact of a given condition depends on both the number of people affected and on how debilitating the condition is for the average patient, most significantly: the extent to which the condition is associated with sick-leave, unemployment and disability (i.e. lost productivity and benefit expenses) and with health care utilisation (i.e. treatment expenses). As a general rule, a broad diagnostic classification will tend to show a weaker association with measures of impact than a more narrow definition, because a large proportion of the cases will have health problems of minor consequence. A highly important question is therefore whether chronic pain, when defined broadly so as to include a large proportion of the population, is associated with a considerable risk of work disability and other negative consequences, or whether the definition is too broad, with the majority of cases experiencing little or no impact on functioning. Here Landmark et al. study is of major importance because it documents these associations in a representative sample using registry data on work participation. The most notable finding was that the disability rate was 32% among those reporting chronic pain, compared to 8% of the remaining population. This translates to a population attributable fraction of 49% (i.e. the proportion disability cases in the population that would be prevented if chronic pain was abolished, assuming a causal relationship). This finding strongly suggests that chronic pain as defined in this study has considerable impact on functioning, despite 31% of the population meeting the case definition. Importantly, it has major implications for health policy: If nearly half the disability cases can be attributed to chronic pain, even minimally effective treatment and preventative programmes for chronic pain may have major impact on the number of disabled individuals and resultant social security costs

3 Replication of findings in an independent data set

As part of the The Status of Public Health in Norway 2010-Report our institute has previously estimated the population attributable proportion of chronic pain on disability with remarkably similar results to those reported by Landmark et al. As the report was cursory, did not include a methods section and is not available in English, this finding will briefly be reported here:

Methods : Data from the 2005 health study conducted by Statistics Norway was analysed. The target population was a random sample of 5000 randomly selected Norwegian individuals aged 16 years or older, stratified by sex and age. Selected individuals were interviewed by phone and completed a follow-up mail-in questionnaire. Interview data included information obtained for 3371 individuals (response rate = 67.4%) and the questionnaire was completed by 2239 individuals (response rate = 44.8%). This sample was restricted post hoc to include only persons aged 26–64 years, so as to omit children, student and pensioners, leaving a final sample of 804 men and 890 women. Chronic pain was defined as present if the subject responded “yes” to the question “Do you have persistent pain that has lasted for 3 months of longer?” and stated that the pain had lasted at least 6 months in the phone interview. The interview also included information on education, which for analytic purposes was dichotomised as low (≤10 years) or high (>10 years). Data on mental health was obtained from the follow-up questionnaire which included the Hopkins Symptom Check List, 25-item version (HSCL) [7]. From this questionnaire one item was dropped (headache) as it was considered overlapping with chronic pain. The remaining items were averaged and a standard cut off of ≥1.75 was applied to identify individuals with probable case-level anxiety and/or depression. Analysis was performed in R version 3.0, using stepwise log-binomial regression, with disability as the dependent variable. Bootstrapping (B =1000) was used to estimate 95% confidence intervals). In Step 1, chronic pain status, sex, age and education were entered as predictors, followed by Step 2, where HSCL status was also included.

Table 1

Risk ratio (RR) for work disability and population attributable fraction (PAF) as a function of chronic pain status. 95% confidence intervals are given in parenthesis. Note that PAF for all risk factors add to more than 100%. This does not reflect an error in the estimation, but ratherthat disability can be prevented by several means in the same individuals, i.e. most profoundly either by removing chronic pain or by arresting ageing (!).

RR P PAF
Step 1
Sex (female) 1.17 (0.89–1.53) n.s 0.09 (-0.07 to 0.23)
Age (per 10 years) 2.21 (1.90–2.65) <0.01 0.81 (0.73 to 0.88)
Education (<11 years) 1.44 (1.10–1.92) <0.01 0.07 (0.02 to 0.14)
Chronic pain 4.66 (3.41–6.47) <0.01 0.56 (0.45 to 0.66)
Step 2
Sex (female) 1.11 (0.96–1.52) n.s 0.06 (-0.03 to 0.22)
Age (per 10 years) 2.20 (1.84–2.64) <0.01 0.81 (0.71 to 0.88)
Education (<11 years) 1.42 (1.11–1.82) <0.01 0.07 (0.02 to 0.13)
HSCL (>1.75) 1.81 (1.43–2.31) <0.01 0.10 (0.05 to 0.16)
Chronic pain 4.30 (3.16-6.21) <0.01 0.54 (0.44 to 0.65)

Results : The prevalence of chronic pain, was 29.5% (compared to 31% for Landmark, et al. [1]) and 9.5% were disabled. As can be seen from Table 1, Step 1, individuals reporting chronic pain are more than four and a half times as likely to be disabled as individuals without chronic pain. This translates to a population attributable fraction of 56%. Surprisingly, these figures were only slightly and non-significantly attenuated when controlling for mental health.

4 Conclusions

Landmark et al. demonstrate that chronic pain, though very common, is strongly associated with negative health outcomes and functioning-most profoundly with work disability, where chronic pain accounts for a population attributable fraction of 49% [1]. The validity of their findings gain strong support from their use of a large representative sample, longitudinal pain measurement, and the inclusion of registry data for work-participation. Furthermore, analysis of independent data presented here yields virtually identical results. Though neither analysis is informative about the causal direction between pain and disability, a recent longitudinal twin study of muscular skeletal conditions with 25 year follow-up strongly suggests that pain is a cause and not a consequence of disability [8]. Taken together these findings provide a compelling incentive for initiating prevention and treatment programmes for chronic pain, in order to reduce disability rates in the population.


DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2013.07.022.



Tel.: +47 21 07 82 77

  1. Conflict of interest: No conflict of interests declared.

References

[1] Landmark T, Romundstad P, Dale O, Borchgrevink PC, Vatten L, Kaasa S. Chronic pain: one year prevalence and associated characteristics (the HUNT pain study). Scand J Pain 2013;4:182–7.Search in Google Scholar

[2] Magni G, Caldieron C, Rigatti-Luchini S, Merskey H. Chronic musculoskeletal pain and depressive symptoms in the general population an analysis of the 1st National Health and Nutrition Examination Survey data. Pain 1990;43: 299–307.Search in Google Scholar

[3] Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480–91.Search in Google Scholar

[4] Ng KF, Tsui SL, Chan WS. Prevalence of common chronic pain in Hong Kong adults. Clin J Pain 2002;18:275–81.Search in Google Scholar

[5] Watkins EA, Wollan PC, Melton III LJ, Yawn BP. A population in pain: report from the Olmsted County health study. Pain Med 2008;9:166–74.Search in Google Scholar

[6] Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–96.Search in Google Scholar

[7] Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sorensen T, Bruusgaard D. Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I. Soc Psychiatry Psychiatr Epidemiol 1998;33:345–54.Search in Google Scholar

[8] Ropponen A, Svedberg P, Kalso E, Koskenvuo M, Silventoinen K, Kaprio J. A prospective twin cohort study of disability pensions due to musculoskeletal diagnoses in relation to stability and change in pain. Pain 2013;10, http://dx.doi.org/10.1016/j.pain.2013.05.029 [Epub ahead of print].Search in Google Scholar

Published Online: 2013-10-01
Published in Print: 2013-10-01

© 2013 Scandinavian Association for the Study of Pain

Articles in the same Issue

  1. Editorial comment
  2. Chronic pain – The invisible disease? Not anymore!
  3. Clinical pain research
  4. New objective findings after whiplash injuries: High blood flow in painful cervical soft tissue: An ultrasound pilot study
  5. Editorial comment
  6. Chronic pain is strongly associated with work disability
  7. Observational studies
  8. Chronic pain: One year prevalence and associated characteristics (the HUNT pain study)
  9. Editorial comment
  10. Pain rehabilitation in general practice in rural areas? It works!
  11. Clinical pain research
  12. Effectiveness of multidisciplinary rehabilitation treatment for patients with chronic pain in a primary health care unit
  13. Editorial comment
  14. Mirror-therapy: An important tool in the management of Complex Regional Pain Syndrome (CRPS)
  15. Topical review
  16. Mirror therapy for Complex Regional Pain Syndrome (CRPS)—A literature review and an illustrative case report
  17. Editorial comment
  18. New insight in migraine pathogenesis: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
  19. Original experimental
  20. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
  21. Editorial comment
  22. Statistical pearls: Importance of effect-size, blinding, randomization, publication bias, and the overestimated p-values
  23. Topical review
  24. Significance tests in clinical research—Challenges and pitfalls
  25. Editorial comment
  26. Biomarkers of pain – Zemblanity?
  27. Topical review
  28. Mechanistic, translational, quantitative pain assessment tools in profiling of pain patients and for development of new analgesic compounds
  29. Editorial comment
  30. Chronic Benign Paroxysmal Positional Vertigo (BPPV): A possible cause of chronic, otherwise unexplained neck-pain, headache, and widespread pain and fatigue, which may respond positively to repeated particle repositioning manoeuvres (PRM)
  31. Observational studies
  32. Pain and other symptoms in patients with chronic benign paroxysmal positional vertigo (BPPV)
  33. Editorial comment
  34. The most important step forward in modern medicine, “a giant leap for mankind”: Insensibility to pain during surgery and painful procedures
  35. Topical review
  36. In praise of anesthesia: Two case studies of pain and suffering during major surgical procedures with and without anesthesia in the United States Civil War-1861–65
  37. Editorial comment
  38. Intravenous non-opioids for immediate postop pain relief in day-case programmes: Paracetamol (acetaminophen) and ketorolac are good choices reducing opioid needs and opioid side-effects
  39. Clinical pain research
  40. Intravenous acetaminophen vs. ketorolac for postoperative analgesia after ambulatory parathyroidectomy
  41. Editorial comment
  42. Scandinavian Association for the Study of Pain 2013—Annual scientific meeting abstracts of pain research presentations and greetings from incoming President
  43. Abstracts
  44. Why does the impact of multidisciplinary pain management on quality of life differ so much between chronic pain patients?
  45. Abstracts
  46. Health care utilization in chronic pain—A population based study
  47. Abstracts
  48. Pain treatment in rural Ghana—A qualitative study
  49. Abstracts
  50. Pain psychology specialist training 2012–2014
  51. Abstracts
  52. Pain assessment, documentation, and management in a university hospital
  53. Abstracts
  54. Promising effects of donepezil when added to patients treated with gabapentin for neuropathic pain
  55. Abstracts
  56. A pediatric patients’ pain evaluation in the emergency unit
  57. Abstracts
  58. Proteomic analysis of cerebrospinal fluid gives insight into the pain relief of spinal cord stimulation
  59. Abstracts
  60. The DQB1(*)03:02 HLA haplotype is associated with increased risk of chronic pain after inguinal hernia surgery and lumbar disc herniation
  61. Abstracts
  62. On the pharmacological effects of two lidocaine concentrations tested on spontaneous and evoked pain in human painful neuroma: A new clinical model of neuropathic pain
  63. Abstracts
  64. The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception
  65. Abstracts
  66. Expression of calcium/calmodulin-dependent protein kinase II in dorsal root ganglia in diabetic rats 6 months and 1 year after diabetes induction
  67. Abstracts
  68. Histamine in the locus coeruleus attenuates neuropathic hypersensitivity
  69. Abstracts
  70. Pronociceptive effects of a TRPA1 channel agonist methylglyoxal in healthy control and diabetic animals
  71. Abstracts
  72. Human inducible pluripotent stem cell-derived sensory neurons express multiple functional ion channels and GPCRs
Downloaded on 26.12.2025 from https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2013.08.002/html
Scroll to top button